Advancements in Predictive Medicine: NLRP3 Inflammasome Inhibitors and AI-Driven Predictive Health Analytics.

Kargbo RB.

Open source

DOI
10.1021/acsmedchemlett.4c00056
Published
2024-02-13
Container
ACS Med Chem Lett
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acsmedchemlett.4c00056,
  title = {Advancements in Predictive Medicine: NLRP3 Inflammasome Inhibitors and AI-Driven Predictive Health Analytics.},
  author = {Kargbo RB.},
  year = {2024},
  journal = {ACS Med Chem Lett},
  doi = {10.1021/acsmedchemlett.4c00056},
  url = {https://doi.org/10.1021/acsmedchemlett.4c00056}
}

RIS

TY  - JOUR
TI  - Advancements in Predictive Medicine: NLRP3 Inflammasome Inhibitors and AI-Driven Predictive Health Analytics.
AU  - Kargbo RB.
PY  - 2024
JO  - ACS Med Chem Lett
DO  - 10.1021/acsmedchemlett.4c00056
UR  - https://doi.org/10.1021/acsmedchemlett.4c00056
ER  - 

APA

RB., K. (2024). Advancements in Predictive Medicine: NLRP3 Inflammasome Inhibitors and AI-Driven Predictive Health Analytics.. ACS Med Chem Lett. https://doi.org/10.1021/acsmedchemlett.4c00056

Source records